We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Medical

Accunea

Status: Unknown

Dec 18th 2019 - Aug 30th 2020

Accunea is the world’s first real-time continuous organ function monitoring company, specializing in biomarkers for kidney transplantation. Targeting NHS hospitals in the UK undertaking renal transplantation, the company aims to provide relief to patients awaiting organ transplants by ensuring availability of more organs for transplant and reducing the numbers of deaths due to increasing waiting list times. For this purpose, the company has designed a miniature analysis device which constantly monitors markers of kidney function and metabolism through a standard dribble line put into the vein of a patient. Accunea is raising £400,000 at a pre-money valuation of £2,230,000. The funds will be used to achieve clinical utility in Kidney and Pancreas.

read more read less

Accunea Rating Review

Pitch rating powered by CROWDRATING

Rated on 19/02/2020

Pitch Rated

71%

overall

Management

80%

Product

76%

Investment

57%

Log in to view amount pledged

    Log in to view target

    £2,229,849
    pre-money valuation

    7
    investors

    £55,434
    pledge per investor

    10661414
    company number

    Active
    company status

    09/03/2017
    incorporated 7 years

    Previous Funding rounds
    09 Jun 24 Shadow Foundr £388,038 / 97% 71.00%
    Officers

What the ratings mean

  • 49% and under
    We suggest potential investors carry out further study of their own
    50-64%
    Room for improvement
    65-79%
    Worth considering
    80%+
    Gold rating, our highest rating

RISK WARNING - The ratings are based on the information provided in the fund raiser’s pitch deck, business plans and financial forecasts which have appeared on a FCA regulated crowdfunding site. Where possible we validate the business plan to public sources such as LinkedIn, Companies House, Credit Agencies and internet searches. We cannot guarantee the information is correct. The ratings report takes no account of the investors/ individual circumstances. Do your own due diligence and get professional advice before investing. Your capital is at risk when investing in private companies.

Login to view the full report

Management 80%

Skills 91%
Accunea's team is highly skilled with vast expertise in medical science, biotechnology, diagnostics, technology, manufacturing and supply chain. The management team is supported by the expertise of a doctor and two professors as their advisors.

0 comments

Log in to comment


Funding progress

Log in to view funding progress.


Log in to view amount pledged

    Log in to view target

    £2,229,849
    pre-money valuation

    7
    investors

    £55,434
    pledge per investor

    10661414
    company number

    Active
    company status

    09/03/2017
    incorporated 7 years

    Previous Funding rounds
    14 Jun 24 Shadow Foundr £388,038 / 97% 71.00%
    Officers
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph